Open Access

Antioxidant capacity of calendula officinalis flowers extract and prevention of radiation induced oropharyngeal mucositis in patients with head and neck cancers: a randomized controlled clinical study

  • Neda Babaee1,
  • Dariush Moslemi2Email author,
  • Mohammad Khalilpour2,
  • Fatemeh Vejdani2,
  • Yasaman Moghadamnia3,
  • Ali Bijani4,
  • Mahmoud Baradaran5,
  • Mohammad Taghi Kazemi5,
  • Asieh Khalilpour6,
  • Mahdi Pouramir6 and
  • Ali Akbar Moghadamnia5
DARU Journal of Pharmaceutical Sciences201321:18

DOI: 10.1186/2008-2231-21-18

Received: 21 January 2013

Accepted: 26 February 2013

Published: 7 March 2013

Abstract

This study was designed to determine the effect of Calendula officinalis flowers extract mouthwash as oral gel on radiation-induced oropharyngeal mucositis (OM) in patients with head-and-neck cancer. Forty patients with neck and head cancers under radiotherapy or concurrent chemoradiotherapy protocols were randomly assigned to receive either 2% calendula extract mouthwash or placebo (20 patients in each group). Patients were treated with telecobalt radiotherapy at conventional fractionation (200 cGy/fraction, five fractions weekly, 30–35 fractions within 4–7 weeks). The oropharyngeal mucositis was evaluated by two clinical investigators (a radiation oncologist and a dentist), using the oral mucositis assessment scale (OMAS). Trying to find out the possible mechanism of action of the treatment, total antioxidant, polyphenol and flavonoid contents, and quercetin concentration of the mouth wash were measured. Calendula mouthwash significantly decreased the intensity of OM compared to placebo at week 2 (score: 5.5 vs. 6.8, p = 0.019), week 3 (score: 8.25 vs. 10.95, p < 0.0001) and week 6 (score: 11.4 vs. 13.35, p = 0.031). Total antioxidant, polyphenol and flavonoid contents and quercetin concentration of the 2% extract were 2353.4 ± 56.5 μM, 313.40 ± 6.52 mg/g, 76.66 ± 23.24 mg/g, and 19.41 ± 4.34 mg/l, respectively. Calendula extract gel could be effective on decreasing the intensity of radiotherapy- induced OM during the treatment and antioxidant capacity may be partly responsible for the effect.

Keywords

Radiotherapy-induced oral mucositis OMAS (oral mucositis assessment scale) Calendula officinalis Antioxidant capacity Gel formulation

Introduction

One of the most commonly perturbing adverse effect of radiotherapy (RT) in head and neck cancers is oropharyngeal mucositis (OM) which comprises the main dose limiting side effect [1]. The OM has been reported by patients to be as the worst side effect of cancer radiotherapy [2, 3]. Triottie et al. stated that the incidence of radiotherapy induced OM in head and neck cancer patients is more than 80% [3]. The OM, as a result of cancer management, is defined as inflammation of oral mucosa, typically manifesting as atrophy, swelling, erythema and ulceration [4]. Up to this date, no approved standard intervention has been found for the prevention or treatment of radiotherapy-induced OM. Several strategies are being actively investigated, which are based on the mechanistic interruption of one or more pathobiological pathways involved in this condition [5]. A large number of treatments and strategies have been studied for OM such as, growth factors, cytokines, antibiotics, anti-inflammatory agents, cryotherapy, mucosal protectors [6, 7] and traditional therapy such as pure honey [8] and herbal medicines [9]. As an example, it has been shown that chamomile mouthwash, is fairly effective on reducing post chemotherapy-induced OM [9].

Calendula officinalis, commonly known as Marigold, is used in the Western and Asian countries for its anti-inflammatory properties [10]. According to some reports, the extract of this plant possesses some pharmacological activities which include antioxidant action, anti–inflammatory, antibacterial, antifungal, and antiviral properties [11]. Results of one clinical trial showed that calendula officinalis was highly effective in the prevention of acute dermatitis in patients with cancer undergoing postoperative irradiation [12]. It was observed that this plant has cytotoxic effect on tumor cell lines in vitro and anticancer activity in vivo[13]. According to the mentioned properties for calendula officinalis such as anti-inflammatory, anti bacterial, and antioxidant effects and considering the pathobiology of OM, it would be interesting to evaluate its effect on radiation-induced OM. Based on these concepts; this study was designed to determine the effect of calendula flowers extract mouthwash as gel formulation in the OM of head and neck cancers radiotherapy.

Methods

Patient selection

In this study forty patients (20 males and 20 females) with a diagnosis of head and neck cancers from Shahid-Rajaie radiotherapy center (Babolsar city, Northern Iran) were recruited. The patients with proven squamous cell cancers of head and neck were randomly divided into two equal groups either received calendula extract mouthwash or placebo (control group). Patients receiving curative radiotherapy or chemoradiotherapy were informed to take oral mouth wash calendula 5 ml b.i.d (12 hours interval). Informed consents were taken from the patients and they were instructed for oral hygiene care, avoiding spicy foods and smoking.

Patients received radiotherapy or chemoradiotherapy with a curative intent. In chemoradiotherapy groups, patients treated concurrent radiotherapy and chemotherapy,receiving cisplatin (100 mg/m2) with or without 5-fluroracil (5-FU) on the first 3 days of the first week then repeated every 3 weeks during treatment period. They were treated using cobalt-60 at 80 cm SSD. Two parallel-opposed lateral fields and an anterior lower neck field were used in daily treatment with a mid-plane radiation dose of 200 cGy to a total of 6000 –7000 cGy in 30–35 treatment sessions. The spinal cord dose was restricted to be <4600 cGy. A boost in dose of 1600–2400 cGy was given to residual disease at the primary site. Shielding blocks were used individually in cases of need. Planning target volume received at least 6000 cGy total radiation dose (200 cGy-5 days/week), with the entire of oropharynx and oral cavity at least 3 cm anterior to the retromolar trigone (no less than one third of the oral cavity) in the primary beam and Karnofsky Performance Status (KPS) >70 were the inclusion criteria.

Exclusion criteria included: history of head and neck radiotherapy, patient’s refusal, comorbid disease (diabetes mellitus, hypertension, collagen vascular disease, systemic infection, cardiac disease, etc.), poor oral hygiene [infection (viral, bacterial or fungal), active gingivitis or oral ulcer] and concurrent medications.

Study design

This investigation was conducted as a placebo-controlled clinical trial. The protocol was approved by Ethics Committee of Babol University of Medical Sciences, Babol, Iran and it was registered in Iranian Registry of Clinical Trials (http://www.irct.ir) with ID No: IRCT201106076734N1. The informed consented patients were divided randomly into two groups of either calendula or placebo (20 patients in calendula group, and 20 patients in placebo group). To consider probable gender effect,we allocated 10 men and 10 women in both calendula and placebo groups. Also to ensure reliable outcomes, the patients’ tumor sites were matched by a radiation oncologist. Radiotherapy was implemented during 30 to 35 sessions in 7 weeks period with an accumulative dose of 6000 to 7000 cGy. From the beginning of radiotherapy, patients were given either placebo or 2% calendula extract mouthwash as a gel formulation. Drugs were administered two times daily, each time 5 ml to be held for at least one minute in oral cavity. This investigation was a double blind study. Calendula and placebo mouthwashes had a same taste, shape and odor. The OM severity in all patients was measured using Oral Mucositis Assessment Scale (OMAS) scores. It is a validated reliable semi quantitative tissue injury scoring scale, with demonstrated intra and inter-observer reproducibility [14]. This scoring system was introduced by Sonis (15) as a simple method to accurately evaluate the mucositis. Oral cavity is divided into 9 regions: hard and soft palate, floor of mouth, upper and lower lips, left and right buccal mucosa, left and right ventral and lateral tongue. All regions of oral cavity had been assessed for erythma and ulcer.

Erythema considered as: 0 point (no erythema), 1 point (mild to moderate erythema) and 2 points (severe erythema). For ulcers as follows: 0 point (no ulcer), 1 point (ulcer <1 cm), 2 points (ulcer 1–3 cm) and 3 points (ulcer >3 cm).

Oropharyngeal mucositis was evaluated by two physicians (a radiation oncologist and a dentist), using the OMAS. Indices were taken weekly during the treatment period. The maximum and minimum scores were 45 and 0, respectively [15]. Considering the treatment period of 7 weeks, 6 indices were provided for each patient.

Mouthwash preparation

Dry and pulverized calendula officinalis flowers were provided from local resources and it was identified and authenticated by herbal section of Department of Pharmacology, Faculty of Medicine, Babol University of Medical Science, Babol, Iran and a voucher specimen (No: CS_00236) was deposited.

Extract of Calendula was made by maceration in ethanol 70% for a 72 hour period. In order to prepare the vehicle of the mouthwash we used following ingredients: Carboxymethyl cellulose (CMC) (15 g), glycerin (25 ml), methyl paraben (1.5 g), prophylparaben (0.2 g), ethanol 95o (10 ml), and distilled water. The alcohol concentration in the final solution was one percent. The vehicle as the base of mouthwash was prepared as follows: first CMC was dissolved in about 250 ml distilled water, then distilled water was added gradually till the primarily volume reached 800 ml, then methyl and prophylparaben were dissolved in glycerin in a temperature of 70 to 100°C. Afterwards 100 ml of primary gel (CMC + DW) was added to them, and then, 10 ml of ethanol in 95° was added. The present solution was mixed to primary gel and remaining distilled was added to this mixture till to reach a maximum volume 1000 ml. After the preparation of mouthwash base, we added 20 g calendula extract for a total volume of 1000 ml, and mixed it till the mixture became uniform, in order to provide 2% calendula mouthwash. The placebo mouthwash is the mouthwash base which has been matched in odor, shape, and taste to calendula mouthwash.

HPLC

Quercetin (main flavonoid aglycon) standard was purchased from Sigma Chemical Co. (St. Louis, MO,USA). Standard stock solution of this aglycone (20 μml-1) was prepared in methanol HPLC grade as a solvent and the linearity of peaks area to concentration (r = 0.983) was calculated using regression analysis. All solvents used for chromatographic purposes were of HPLC grade. HPLC was performed using a Knauer Smartline Liquid Chromatography System (Knauer, Germany) that consisted of a four-channel pump, UV/VIS detector and an injection valve, to which a 20 μl sample loop was attached. Data acquisition and processing were performed on a personal computer using Chromgate software. Sample injections were performed using a 100 μl syringe (Hamilton, Reno, Nevada, USA). The column was a Prontosil #60-5, C18 H column that was 4.6 mm in diameter and 250 mm in length. A purification system (HastaranTeb Co, FNR12, Tehran, Iran) was used for the filtration (deionization) of water. Chromatographic analysis was carried out using a single-column isocratic reverse-phase method. The mobile phase consisted of a 40:60 mixture of methanol and water containing 0.5% orthophosphoric acid. A flow rate of 0.8 mL/min was used. The analytes were detected by UV absorption at 290 nm. The standard curve of quercetin was prepared using standard solutions of different concentrations (20, 10, 4, 2 and 1 μgml-1). The volume for each injection was 20 μl.

Sample Preparation for HPLC analysis: The plant flowers (100 mg) with 6 ml 25% hydrochloric acid and 94 ml methanol was extracted and filtered through a 13 mm, 2-μm pore, using Whatman filter. The filtrate was finally diluted with methanol in the ratio 1:2 and 10 μl of this solution was injected for HPLC analysis. Each extract was diluted and injected in five repeats.

Determination of total antioxidant activity

Total antioxidant activity was estimated by a FRAP (ferric reducing antioxidant power) assay [16]. Five different concentrations of the calendula extracts (0.1, 0.2, 0.4, 0.5, 1%) were used for this test. Principle of this method is based on the reduction of a ferric-tripyridyltriazine complex to its ferrous, colored form in the presence of antioxidants and the absorbance was read at 593 nm with a single beam Jenway UV/Visible spectrophotometer (UK) and compared to a blank. The final result was expressed as the concentration of antioxidant with a ferric reducing ability equivalent to that of 1 mmol/l FeSO4 [17].

Total phenols determination

Total phenolic contents were evaluated using Folin-Ciocalteu reagent [18]. A dilute solution of the extract (0.5 ml of 1:100 mg ml-1 methanolic extract) or gallic acid (phenolic standard compound) was mixed with the reagent (5 ml, 1:10 diluted with distilled water) and aqueous Na2CO3 (4 ml, 1 M). After 15 min standby period, the total phenol contents were assayed using colorimetry at 765 nm. The standard curve was obtained using 0, 25, 50, 100, 150, 250 and 500 mg l-1 solutions of gallic acid in methanol:water (50:50, v/v). Total phenolic contents were shown as mg/g (of dry mass) of gallic acid equivalent, which is a common reference compound.

Total flavonoids determination

Total flavonoid contents were determined using aluminum chloride colorimetric method [19]. Calendula methanolic extract (0.5 ml of %1 extract) was mixed with 1.5 ml of methanol, 0.1 ml of 10% aluminum chloride, 0.1 ml of 1 M potassium acetate and 2.8 ml of distilled water. Then the mixture was left at room temperature for 30 min; the absorbance of the reaction mixture was measured at 415 nm. Different quercetin solutions at concentrations 6.25, 12.5, 25, 50 and 100 mg l-1 in methanol were prepared to obtaining standard curve.

Statistical analysis

Data were analyzed by using t-test, Mann–Whitney U test, one-way ANOVA and repeated measures ANOVA tests. The p values of less than 0.05 were considered as the statistical significant difference.

Results

In the pcacebo group , six patients were excluded : Four patients had left the study , two patients had severe mucositis and treated with another drugs. In the calendula group ,three patients were exclude that had left the study. Statistical analysis was performed on 20 and18 patients in calendula and placebo groups respectively (Additional file 1). Thirty eight patients with mean age 54.1 (range 46–72) completed the study. Individual characteristics of the patients are detailed in Table 1. None of the patients in calendula group underwent medication for OM severity and radiotherapy was not ceased for this reason. In calendula group three patients did not show OM in the whole treatment period. OM intensity was measured according to OMAS scores at the end of each week for both calendula and placebo groups. OMAS scores were significantly lower in calendula group compared to placebo at week 2, 3 and 6 of the study (Figure 1). According to repeated measures ANOVA test, the differences between OMAS of calendula and placebo during the weeks of evaluation were statistical significant (p < 0.001) and OM intensity was significantly decreased in calendula compared to placebo group (p = 0.048). Although OM intensity was higher in women, but in both group of genders calendula had better results compared to placebo (Figure 2). Quercetin concentration as a main flavonoid content was measured. According to the standard curve, the mean ± SD of quercetin concentration in the extract was 19.41 ± 4.34 mg/l (%RSD = 15.33). HPLC fingerprint of hydroalcolic extract of calendula officinalis is shown in Figure 3. The flavonoid contents of calendula flowers extract based on quercetin equivalent concentration (the standard curve equation: y =0.007× + 0.3337, r = 0.998) was 76.66 ± 23.24 mg/g.
Table 1

Comparison of the patients’ individual results in among two treatment groups

Treatment groups

Placebo

Calendula extract

Parameters

Number of patients

20

20

Male

10

10

female

10

10

Mean age

52.8

52.2

Tumor location

  

Nasopharynx

10

11

Oral Cavity

7

6

Salivary glands

1

-

Tonsil

2

3

Radiotherapy alone

4

3

Chemoradiotherapy

16

17

Total

20

20

https://static-content.springer.com/image/art%3A10.1186%2F2008-2231-21-18/MediaObjects/40199_2013_Article_128_Fig1_HTML.jpg
Figure 1

Mean (±SEM) of OMAS scores changes by time (week) in placebo and calendula treatment group. * p = 0.019, ** p < 0.0001, *** p = 0.031.

https://static-content.springer.com/image/art%3A10.1186%2F2008-2231-21-18/MediaObjects/40199_2013_Article_128_Fig2_HTML.jpg
Figure 2

Mean (±SEM) of OMAS scores changes by sex and time (week) in placebo and calendula treatment group.

The FRAP results for ferric reducing ability in five concentrations (0.1, 0.2, 0.4, 0.5, and 1%) of calendula extracts were 565.5 ± 126.5, 1059.2 ± 305.1, 1714.3 ± 318.5, 1877.3 ± 381.8 and 2353.4 ± 56.5 μM, respectively. Total phenol using gallic acid concentration (the standard curve equation: y =0.005× + 0.001, r = 0.999) was 313.40 ± 6.52 mg/g of gallic acid equivalent in the extract of calendula officinalis.
https://static-content.springer.com/image/art%3A10.1186%2F2008-2231-21-18/MediaObjects/40199_2013_Article_128_Fig3_HTML.jpg
Figure 3

HPLC fingerprint obtained from hydroalcolic extract of calendula officinalis flowers (A), compared to quercetin standard [Q, 20 microgram/ml] (B). Method characteristics: methanol (40%), 0.5% aqueous solution of orthophosphpric acid (0.6%), flow rate, 0.8 ml/min, detection at 290 nm.

Discussion

When biological changes induced by radiotherapy is being initiated, an extensive damage is seen to result in destruction of intact mucosa [20]. In the present study three patients of calendula group didn’t demonstrate OM after radiotherapy in the whole treatment period.

Most interventions have been proven to be ineffective and current clinical management of OM is mainly palliative and focused on pain control [21]. Up to date, no study has investigated the effect of calendula officinalis on radiation-induced OM. Many beneficial activities reported for the plant are mainly related to the contents of various secondary metabolites such as polyphenols, cartenoids, triterpenes and essential oils [22]. Several calendula therapeutic properties such as, anti-inflammatory, anti-tumorogenic [23, 24] have been reported. In addition, in vitro anti-microbial activities of its oils have been proven [25]. Regardless of bacterial counts which may increase over 300% compared to baseline, increasing gram negative bacteria that is seen during ulceration needs to be re-established by normal bacterial proportions for spontaneous ulcer resolution [26]. Antioxidant activity and wound healing properties of calendula has been reported [27]. According to the present results, antioxidant activity of the extract was confirmed. It has been demonstrated that plant polyphenols such as flavonoids are a most important active natural products possessing antioxidant activity. This effect is considerable on human health. The flavonoids which contain hydroxyl groups are responsible for the radical scavenging [2830] or chelating [3133] effects. These agents accompanying with several endogenous antioxidants may play an prominent role in maximum protection against oxidative stress induced by high level of reactive oxygen species (ROS) in the body. On the other hand, phenolic compounds are a class of antioxidant agents which act as free radical terminators [34, 35]. The ROS play a causative role in several degenerative diseases, for example heart disease, atherosclerosis, hepatotoxicity, inflammation, tumor promotion, and cancer [3638]. In this study quercetin as a flavonoid with anti-inflammatory effect [3941] has been assayed in the calendula flower extract and antioxidant capacity was measured using FRAP test as well.

According to our investigation, the high contents of the flovonoid and phenolic phytochemicals in calendula officinalis and its antioxidant activity can support its high radical scavenging activity and following protective effect in radiotherapy- induced OM. Initiation phase of radiotherapy or chemotherapy-induced injury is a critical first step in the development of mucositis in which clonogenic cell death and the production of ROS by injured cells are the most dominant components. The initiation phase is a rate-limiting step and by delaying or stopping it, it can be prevented or minimized by regimen-related injury [42]. Considering the antioxidant properties of calendula, it may act against ROS and prevents or delays the initiation phase. In one study which evaluated laser activated calendula extract (LACE), the LACE showed to be capable in vitro inhibition of tumor cell proliferation, from 70 to 100% when tested on a wide variety of human and murine tumor cell lines. According to this study, LACE has immune-modulatory activities [5, 23, 43]. There is very few safety concerns related to calendula. However, systemic administration of calendula products should be avoided during early stages of pregnancy due to its ability to stimulate menstruation, also allergic hypersensitivity may cause a problem for individuals sensitive to other members of the plant family asteraceae[44]. It has been shown that calendula extract toothpaste could effectively reduce plaque and bleeding indexes in moderate to severe gingivitis. It has been suggested that anti-inflammatory, antibacterial and antioxidant properties of calendula may be responsible for mentioned effects on gingivitis [45]. On the other hand, it has been reported calendula flowers extract as an ointment is effective in relieving pain of cracked or tender nipples [46]. Duran et. al. (1996), showed positive preliminary results for the administration of calendula ointment in the treatment of venous leg ulcers [47]. It has been demonstrated that calendula as a cream preparation protected skin from irritant contact dermatitis caused by exposure to sodium lauryl sulfate [48]. And as earlier mentioned, calendula was highly effective in the prevention of acute dermatitis in patients with cancer undergoing postoperative irradiation [12]. Although, dermatitis and OM have different pathobiology profiles, among reviewed clinical trials the mentioned study was the closest one to our investigation. Generally there are few studies concerning effects of herbal extracts on OM. The fact that calendula mouthwash could not completely prevent OM can be explained by the complicated pathobiology of OM. It is also suggested using calendula preparations in high dose of in order to be more effective, and it perhaps need to be applied for a longer duration of time, even though different protocols for herbal extraction should be considered as a factor when evaluating its effects. In the present study, alcohol containing mouthwash was used. Although the concentration of alcohol in final solution was lower than to induce injury to the oral mucosa, the irritant effect of alcohol may be questionable. In other words, it has been found that chlorhexidine mouthwash containing alcohol, can irritate the oral mucosa and it is effective in reducing the duration of pain associated with oral mucositis induced by chemotherapy (49). Regarding to comparison of OM in two genders, it has been demonstrated that its intensity is higher in females than males. Severe stomatitises and radiotherapy induced OM, has been reported in women [49]. This may be due to physiological differences between two sexes but its exact mechanism remains to be elucidated.

Finally, it is concluded that calendula officinalis is effective on decreasing OM intensity but cannot completely prevent its occurance. All patients could tolerate it without any significant side effects (i.e., nausea and vomiting). Furhter investigations are recommended to elucidate the optimal dose and administration frequency to have better outcomes in radiotherapy-induced OM.

Declarations

Acknowledgements

The authors would like to thank department of research affairs of Babol University of Medical Sciences, for the financial support.

Authors’ Affiliations

(1)
Department of Oral diseases, School of Dentistry, Babol University of Medical Sciences
(2)
Division of Radiation Oncology, School of Medicine, Babol University of Medical Sciences
(3)
School of Basic Sciences, Alzahra University
(4)
Non-Communicable Pediatric Disease Research Center, Babol University of Medical Sciences
(5)
Department of Pharmacology, School of Medicine, Babol University of Medical Sciences
(6)
Department of Biochemistry, School of Medicine, Babol University of Medical Sciences

References

  1. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS: Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer. 2004, 100: 2026-2046. 10.1002/cncr.20163.View ArticlePubMedGoogle Scholar
  2. Sonis ST: A biological approach to mucositis. J Support Oncol. 2004, 2: 21-32. discussion 35–26PubMedGoogle Scholar
  3. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, Komaroff E: Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol. 2003, 66: 253-262. 10.1016/S0167-8140(02)00404-8.View ArticlePubMedGoogle Scholar
  4. Raber-Durlacher JE, Elad S, Barasch A: Oral mucositis. Oral Oncol. 2010, 46: 452-456. 10.1016/j.oraloncology.2010.03.012.View ArticlePubMedGoogle Scholar
  5. Watkins B, Pouliot K, Fey E, Tuthill C, Sonis S: Attenuation of radiation- and chemoradiation-induced mucositis using gamma-D-glutamyl-L-tryptophan (SCV-07). Oral Dis. 2010, 16: 655-660. 10.1111/j.1601-0825.2010.01671.x.View ArticlePubMedGoogle Scholar
  6. Lalla RV, Peterson DE: Treatment of mucositis, including new medications. Cancer J. 2006, 12: 348-354. 10.1097/00130404-200609000-00004.View ArticlePubMedGoogle Scholar
  7. Lalla RV, Sonis ST, Peterson DE: Management of oral mucositis in patients who have cancer. Dent Clin North Am. 2008, 52: 61-77. 10.1016/j.cden.2007.10.002.PubMed CentralView ArticlePubMedGoogle Scholar
  8. Motallebnejad M, Akram S, Moghadamnia A, Moulana Z, Omidi S: The effect of topical application of pure honey on radiation-induced mucositis: a randomized clinical trial. J Contemp Dent Pract. 2008, 9: 40-47.PubMedGoogle Scholar
  9. Shabanloei R, Ahmadi F, Vaez J, Ansarin K, Hajizadeh E, Javadzadeh Y, Dolatkhah R: Alloprinol, chamomile and normal saline mouthwashes for the prevention of chemotehrapy-induced stomatitis. J Clin Diagn Res. 2009, 3: 1537-1542.Google Scholar
  10. Akihisa T, Yasukawa K, Oinuma H, Kasahara Y, Yamanouchi S, Takido M, Kumaki K: Triterpene alcohols from the flowers of compositae and their anti-inflammatory effects. Phytochemistry. 1996, 43: 1255-1260. 10.1016/S0031-9422(96)00343-3.View ArticlePubMedGoogle Scholar
  11. Chandran PK, Kuttan R: Effect of calendula officinalis flower extract on acute phase proteins, antioxidant defense mechanism and granuloma formation during thermal burns. J Clin Biochem Nutr. 2008, 43: 58-64. 10.3164/jcbn.2008043.PubMed CentralView ArticlePubMedGoogle Scholar
  12. Pommier P, Gomez F, Sunyach MP, D’Hombres A, Carrie C, Montbarbon X: Phase III randomized trial of calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol. 2004, 22: 1447-1453. 10.1200/JCO.2004.07.063.View ArticlePubMedGoogle Scholar
  13. Boucaud-Maitre Y, Algernon O, Raynaud J: Cytotoxic and antitumoral activity of calendula officinalis extracts. Pharmazie. 1988, 43: 220-221.PubMedGoogle Scholar
  14. Greenberg M: Burket’s Oral medicine. 2008, Hamilton, Ontario: BC Decker Inc, 178-179. 11Google Scholar
  15. Sonis ST, Eilers JP, Epstein JB, LeVeque FG, Liggett WH, Mulagha MT, Peterson DE: Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer. 1999, 85: 2103-2113. 10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0.View ArticlePubMedGoogle Scholar
  16. Benzie IF, Strain JJ: The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 1996, 239: 70-76. 10.1006/abio.1996.0292.View ArticlePubMedGoogle Scholar
  17. Busserolles J, Gueux E, Balasinska B, Piriou Y, Rock E, Rayssiguier Y, Mazur A: In vivo antioxidant activity of procyanidin-rich extracts from grape seed and pine (pinus maritima) bark in rats. Int J Vitam Nutr Res. 2006, 76: 22-27. 10.1024/0300-9831.76.1.22.View ArticlePubMedGoogle Scholar
  18. McDonald S, Prenzler PD, Antolovich M, Robards K: Phenolic content and antioxidant activity of olive extracts. Food Chemist. 2001, 73: 73-84. 10.1016/S0308-8146(00)00288-0.View ArticleGoogle Scholar
  19. Chang CC, Yang MH, Wen HM, Chern JC: Estimation of total flavonoid content in propolis by two complementary colorimetric methods. J Food Drug Analysis. 2002, 10: 178-182.Google Scholar
  20. Sonis ST: Mucositis: the impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol. 2009, 45: 1015-1020. 10.1016/j.oraloncology.2009.08.006.View ArticlePubMedGoogle Scholar
  21. Lopes NN, Plapler H, Lalla RV, Chavantes MC, Yoshimura EM, da Silva MA, Alves MT: Effects of low-level laser therapy on collagen expression and neutrophil infiltrate in 5-fluorouracil-induced oral mucositis in hamsters. Lasers Surg Med. 2010, 42: 546-552. 10.1002/lsm.20920.View ArticlePubMedGoogle Scholar
  22. Kishimoto S, Maoka T, Sumitomo K, Ohmiya A: Analysis of carotenoid composition in petals of calendula (calendula officinalis L). Biosci Biotechnol Biochem. 2005, 69: 2122-2128. 10.1271/bbb.69.2122.View ArticlePubMedGoogle Scholar
  23. Jimenez-Medina E, Garcia-Lora A, Paco L, Algarra I, Collado A, Garrido F: A new extract of the plant calendula officinalis produces a dual in vitro effect: cytotoxic anti-tumor activity and lymphocyte activation. BMC Cancer. 2006, 6: 119-10.1186/1471-2407-6-119.PubMed CentralView ArticlePubMedGoogle Scholar
  24. Hamburger M, Adler S, Baumann D, Forg A, Weinreich B: Preparative purification of the major anti-inflammatory triterpenoid esters from marigold (calendula officinalis). Fitoterapia. 2003, 74: 328-338. 10.1016/S0367-326X(03)00051-0.View ArticlePubMedGoogle Scholar
  25. Sarrell EM, Cohen HA, Kahan E: Naturopathic treatment for ear pain in children. Pediatrics. 2003, 111: e574-e579. 10.1542/peds.111.5.e574.View ArticlePubMedGoogle Scholar
  26. Donnelly JP, Bellm LA, Epstein JB, Sonis ST, Symonds RP: Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infect Dis. 2003, 3: 405-412. 10.1016/S1473-3099(03)00668-6.View ArticlePubMedGoogle Scholar
  27. Lavagna SM, Secci D, Chimenti P, Bonsignore L, Ottaviani A, Bizzarri B: Efficacy of Hypericum and calendula oils in the epithelial reconstruction of surgical wounds in childbirth with caesarean section. Farmaco. 2001, 56: 451-453. 10.1016/S0014-827X(01)01060-6.View ArticlePubMedGoogle Scholar
  28. Heijnen CG, Haenen GR, van Acker FA, van der Vijgh WJ, Bast A: Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups. Toxicol In Vitro. 2001, 15: 3-6. 10.1016/S0887-2333(00)00053-9.View ArticlePubMedGoogle Scholar
  29. Sakao K, Fujii M, Hou DX: Clarification of the role of quercetin hydroxyl groups in superoxide generation and cell apoptosis by chemical modification. Biosci Biotechnol Biochem. 2009, 73: 2048-2053. 10.1271/bbb.90253.View ArticlePubMedGoogle Scholar
  30. Younes M, Siegers CP: Inhibitory action of some flavonoids on enhanced spontaneous lipid peroxidation following glutathione depletion. Planta Med. 1981, 43: 240-244. 10.1055/s-2007-971503.View ArticlePubMedGoogle Scholar
  31. Cook NC, Samman S: Flavonoids - chemistry, metabolism, cardioprotective effects, and dietary sources. J Nutri Biochemist. 1996, 7: 66-76. 10.1016/0955-2863(95)00168-9.View ArticleGoogle Scholar
  32. Kessler M, Ubeaud G, Jung L: Anti- and pro-oxidant activity of rutin and quercetin derivatives. J Pharm Pharmacol. 2003, 55: 131-142. 10.1211/002235702559.View ArticlePubMedGoogle Scholar
  33. Mandel SA, Avramovich-Tirosh Y, Reznichenko L, Zheng H, Weinreb O, Amit T, Youdim MB: Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway. Neurosignals. 2005, 14: 46-60. 10.1159/000085385.View ArticlePubMedGoogle Scholar
  34. Jacobo-Velazquez DA, Cisneros-Zevallos L: Correlations of antioxidant activity against phenolic content revisited: a new approach in data analysis for food and medicinal plants. J Food Sci. 2009, 74: R107-R113. 10.1111/j.1750-3841.2009.01352.x.View ArticlePubMedGoogle Scholar
  35. Es-Safi NE, Ghidouche S, Ducrot PH: Flavonoids: hemisynthesis, reactivity, characterization and free radical scavenging activity. Molecules. 2007, 12: 2228-2258. 10.3390/12092228.View ArticlePubMedGoogle Scholar
  36. Hogg N: Free radicals in disease. Semin Reprod Endocrinol. 1998, 16: 241-248. 10.1055/s-2007-1016284.View ArticlePubMedGoogle Scholar
  37. Zhang N, Andresen BT, Zhang C: Inflammation and reactive oxygen species in cardiovascular disease. World J Cardiol. 2: 408-410.
  38. Shackelford RE, Kaufmann WK, Paules RS: Oxidative stress and cell cycle checkpoint function. Free Radic Biol Med. 2000, 28: 1387-1404. 10.1016/S0891-5849(00)00224-0.View ArticlePubMedGoogle Scholar
  39. Backhouse N, Rosales L, Apablaza C, Goity L, Erazo S, Negrete R, Theodoluz C: Analgesic, anti-inflammatory and antioxidant properties of Buddleja globosa, Buddlejaceae. J Ethnopharmacol. 2008, 116: 263-269. 10.1016/j.jep.2007.11.025.View ArticlePubMedGoogle Scholar
  40. Hamalainen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E: Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm. 2007, 2007: 45673-PubMed CentralView ArticlePubMedGoogle Scholar
  41. Loke WM, Proudfoot JM, Stewart S, McKinley AJ, Needs PW, Kroon PA, Hodgson JM: Metabolic transformation has a profound effect on anti-inflammatory activity of flavonoids such as quercetin: lack of association between antioxidant and lipoxygenase inhibitory activity. Biochem Pharmacol. 2008, 75: 1045-1053. 10.1016/j.bcp.2007.11.002.View ArticlePubMedGoogle Scholar
  42. Sonis ST: New thoughts on the initiation of mucositis. Oral Dis. 2010, 16: 597-600. 10.1111/j.1601-0825.2010.01681.x.View ArticlePubMedGoogle Scholar
  43. Park HR, Jo SK, Paik SG: Factors effecting the Th2-like immune response after gamma-irradiation: low production of IL-12 heterodimer in antigen-presenting cells and small expression of the IL-12 receptor in T cells. Int J Radiat Biol. 2005, 81: 221-231. 10.1080/09553000500077088.View ArticlePubMedGoogle Scholar
  44. Brinker F: Herb contraindications and drug interactions. 2001, Eclectic Medical Publications: Sandy, 3Google Scholar
  45. Amoian B, Moghadamnia AA, Mazandarani M, Amoian MM, Mehrmanesh S: The effect of calendula extract toothpaste on the plaque index and bleeding in gingivitis. J Med Plant. 2010, 4: 132-140.View ArticleGoogle Scholar
  46. Loggia D, Tubaro A, Sosa S: The role of triterpenoids in the topical anti-inflammatory activity of calendula officinialis [sic] flowers. Planta Med. 1994, 60: 516-520. 10.1055/s-2006-959562.View ArticlePubMedGoogle Scholar
  47. Duran V, Matic M, Jovanovc M, Mimica N, Gajinov Z, Poljacki M, Boza P: Results of the clinical examination of an ointment with marigold (calendula officinalis) extract in the treatment of venous leg ulcers. Int J Tissue React. 2005, 27: 101-106.PubMedGoogle Scholar
  48. Fuchs SM, Schliemann-Willers S, Fischer TW, Elsner P: Protective effects of different marigold (calendula officinalis L.) and rosemary cream preparations against sodium-lauryl-sulfate-induced irritant contact dermatitis. Skin Pharmacol Physiol. 2005, 18: 195-200. 10.1159/000085865.View ArticlePubMedGoogle Scholar
  49. Sloan JA, Loprinzi CL, Novotny PJ, Okuno S, Nair S, Barton DL: Sex differences in fluorouracil-induced stomatitis. J Clin Oncol. 2000, 18: 412-420.PubMedGoogle Scholar

Copyright

© Babaee et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement